These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7929804)

  • 1. Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex.
    Xin Z; Tang H; Ganea D
    J Neuroimmunol; 1994 Oct; 54(1-2):59-68. PubMed ID: 7929804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vasoactive intestinal peptide (VIP) on cytokine production and expression of VIP receptors in thymocyte subsets.
    Xin Z; Jiang X; Wang HY; Denny TN; Dittel BN; Ganea D
    Regul Pept; 1997 Sep; 72(1):41-54. PubMed ID: 9404731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex.
    Sun L; Ganea D
    J Neuroimmunol; 1993 Oct; 48(1):59-69. PubMed ID: 7901234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide downregulates the expression of IL-2 but not of IFN gamma from stimulated murine T lymphocytes.
    Ganea D; Sun L
    J Neuroimmunol; 1993 Sep; 47(2):147-58. PubMed ID: 8103776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism.
    Wang HY; Xin Z; Tang H; Ganea D
    J Immunol; 1996 May; 156(9):3243-53. PubMed ID: 8617946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes.
    Martinez C; Delgado M; Gomariz RP; Ganea D
    J Immunol; 1996 Jun; 156(11):4128-36. PubMed ID: 8666779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of cytokine expression in murine lymphocytes by PACAP and VIP.
    Tang H; Sun L; Xin Z; Ganea D
    Ann N Y Acad Sci; 1996 Dec; 805():768-78. PubMed ID: 8993475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogen-induced IL-2 production and proliferation at defined stages of T helper cell development.
    Chang JF; Thomas CA; Kung JT
    J Immunol; 1991 Aug; 147(3):860-6. PubMed ID: 1830601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of mouse T-cell proliferation by CGRP and VIP: effects of these neuropeptides on IL-2 production and cAMP synthesis.
    Boudard F; Bastide M
    J Neurosci Res; 1991 May; 29(1):29-41. PubMed ID: 1653367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide enhancement of antigen-induced differentiation of a cultured line of mouse thymocytes.
    Pankhaniya R; Jabrane-Ferrat N; Gaufo GO; Sreedharan SP; Dazin P; Kaye J; Goetzl EJ
    FASEB J; 1998 Jan; 12(1):119-27. PubMed ID: 9438417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory effects of vasoactive intestinal peptide on cytokine production in central and peripheral lymphoid organs.
    Ganea D
    Adv Neuroimmunol; 1996; 6(1):61-74. PubMed ID: 8790782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VIP1 and VIP2 receptors but not PVR1 mediate the effect of VIP/PACAP on cytokine production in T lymphocytes.
    Jiang X; Wang HY; Yu J; Ganea D
    Ann N Y Acad Sci; 1998 Dec; 865():397-407. PubMed ID: 9928038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of calcitonin gene-related peptide and vasoactive intestinal peptide on murine CD4 and CD8 T cell proliferation.
    Teresi S; Boudard F; Bastide M
    Immunol Lett; 1996 Apr; 50(1-2):105-13. PubMed ID: 8793567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes.
    Freywald A; Sharfe N; Miller CD; Rashotte C; Roifman CM
    J Immunol; 2006 Apr; 176(7):4066-74. PubMed ID: 16547242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoactive intestinal peptide stimulates p59fyn kinase activity in murine thymocytes.
    Xin Z; Sun L; Ganea D
    Peptides; 1997; 18(8):1151-9. PubMed ID: 9396055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine T-lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA.
    Johnson MC; McCormack RJ; Delgado M; Martinez C; Ganea D
    J Neuroimmunol; 1996 Aug; 68(1-2):109-19. PubMed ID: 8784267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine thymocytes with ability to inhibit Il-2 production: I. Genetic differences between mouse strains and characterization of the model system.
    Gigliotti D; Nihlmark EL; Wigzell H; Hansson M
    APMIS; 1992 Jan; 100(1):71-80. PubMed ID: 1531594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue of thymocytes and T cell hybridomas from glucocorticoid-induced apoptosis by stimulation via the T cell receptor/CD3 complex: a possible in vitro model for positive selection of the T cell repertoire.
    Iwata M; Hanaoka S; Sato K
    Eur J Immunol; 1991 Mar; 21(3):643-8. PubMed ID: 1826261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasoactive intestinal peptide inhibits cytokine production in T lymphocytes through cAMP-dependent and cAMP-independent mechanisms.
    Wang HY; Jiang X; Gozes I; Fridkin M; Brenneman DE; Ganea D
    Regul Pept; 1999 Oct; 84(1-3):55-67. PubMed ID: 10535409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.